Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BICX NYSEAMERICAN:CCEL NYSE:CCM NASDAQ:MRAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBICXBiocorrx$0.40+17.6%$0.37$0.20▼$1.28$10.03M0.17372 shs6,090 shsCCELCryo-Cell International$3.61+8.1%$3.54$2.72▼$5.43$26.90M0.4910,045 shs11,059 shsCCMConcord Medical Services$4.74+7.9%$4.74$3.18▼$10.77$19.06M-0.9735,756 shs45,702 shsMRAIMarpai$0.70-2.8%$0.50$0.22▼$1.78$18.63M4.9257,936 shs3,395 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBICXBiocorrx0.00%0.00%-9.93%-15.00%-5.56%CCELCryo-Cell International0.00%+15.17%-4.43%-4.02%-33.86%CCMConcord Medical Services0.00%-6.40%-7.31%+15.53%-26.21%MRAIMarpai0.00%-1.83%+23.16%+155.27%-48.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBICXBiocorrx$0.40+17.6%$0.37$0.20▼$1.28$10.03M0.17372 shs6,090 shsCCELCryo-Cell International$3.61+8.1%$3.54$2.72▼$5.43$26.90M0.4910,045 shs11,059 shsCCMConcord Medical Services$4.74+7.9%$4.74$3.18▼$10.77$19.06M-0.9735,756 shs45,702 shsMRAIMarpai$0.70-2.8%$0.50$0.22▼$1.78$18.63M4.9257,936 shs3,395 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBICXBiocorrx0.00%0.00%-9.93%-15.00%-5.56%CCELCryo-Cell International0.00%+15.17%-4.43%-4.02%-33.86%CCMConcord Medical Services0.00%-6.40%-7.31%+15.53%-26.21%MRAIMarpai0.00%-1.83%+23.16%+155.27%-48.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBICXBiocorrx 2.00HoldN/AN/ACCELCryo-Cell International 2.00HoldN/AN/ACCMConcord Medical Services 1.00SellN/AN/AMRAIMarpai 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BICX, CCEL, MRAI, and CCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/26/2026CCMConcord Medical Services Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBICXBiocorrx$800K14.75N/AN/A($0.47) per share-0.85CCELCryo-Cell International$31.57M0.92N/AN/A($2.31) per share-1.56CCMConcord Medical Services$65.85M0.31$2.01 per share2.36$60.94 per share0.08MRAIMarpai$34.87M0.53N/AN/A($1.72) per share-0.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBICXBiocorrx-$3.44M-$0.16N/AN/AN/AN/AN/A-73.40%8/17/2026 (Estimated)CCELCryo-Cell International-$2.43M-$1.06N/AN/AN/A-8.52%N/A-4.26%N/ACCMConcord Medical Services-$13.27MN/AN/AN/AN/AN/AN/AN/AN/AMRAIMarpai-$28.75M-$0.87N/AN/AN/A-85.70%N/A-100.23%8/12/2026 (Estimated)Latest BICX, CCEL, MRAI, and CCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026BICXBiocorrx-$0.06-$0.03+$0.03-$0.03$0.22 million$0.22 million4/29/2026Q4 2025CCMConcord Medical ServicesN/A-$1.08N/A-$1.08N/AN/A4/14/2026Q1 2026CCELCryo-Cell InternationalN/A$0.01N/A$0.01N/A$7.68 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBICXBiocorrxN/AN/AN/AN/AN/ACCELCryo-Cell InternationalN/AN/AN/AN/AN/ACCMConcord Medical ServicesN/AN/AN/AN/AN/AMRAIMarpaiN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBICXBiocorrxN/A0.120.10CCELCryo-Cell InternationalN/A0.620.60CCMConcord Medical Services1.330.480.46MRAIMarpaiN/A0.820.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBICXBiocorrxN/ACCELCryo-Cell International10.44%CCMConcord Medical ServicesN/AMRAIMarpai49.75%Insider OwnershipCompanyInsider OwnershipBICXBiocorrx21.40%CCELCryo-Cell International38.59%CCMConcord Medical Services46.50%MRAIMarpai46.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBICXBiocorrx329.50 million23.19 millionNot OptionableCCELCryo-Cell International908.06 million4.95 millionNot OptionableCCMConcord Medical Services9704.34 million2.32 millionNot OptionableMRAIMarpai15026.61 million5.61 millionNo DataBICX, CCEL, MRAI, and CCM HeadlinesRecent News About These CompaniesMarpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA ...May 27, 2026 | tmcnet.comMarpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026May 26, 2026 | prnewswire.comMARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSMay 15, 2026 | prnewswire.comMarpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for ProfitabilityMay 11, 2026 | prnewswire.comMarpai Extends Maturity of Insider Promissory NotesMay 1, 2026 | tipranks.comMarpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth NationwideApril 1, 2026 | prnewswire.comMarpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered LivesMarch 9, 2026 | prnewswire.comMarpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform ExpansionFebruary 23, 2026 | prnewswire.comMARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTHJanuary 27, 2026 | prnewswire.comMarpai consolidates leadership as CEO Damien Lamendola becomes PresidentJanuary 23, 2026 | tipranks.comMARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSIONDecember 1, 2025 | prnewswire.comMarpai, Inc. Earnings Call Highlights Mixed SentimentNovember 14, 2025 | msn.comMARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTSNovember 12, 2025 | prnewswire.comMarpai Signs Material Definitive AgreementNovember 12, 2025 | tipranks.comMARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTSNovember 6, 2025 | prnewswire.comMarpai Authorizes 2 Million Blank-Check Preferred SharesOctober 21, 2025 | msn.comMarpai Announces Compliance with Securities Exchange ActOctober 19, 2025 | theglobeandmail.comMARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOROctober 14, 2025 | prnewswire.comMARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUNDOctober 6, 2025 | prnewswire.comMarpai, Inc. Earnings Call: Mixed Results and Strategic ShiftsAugust 31, 2025 | tipranks.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Oil Trade May Not Be Over: 3 Energy Stocks to WatchBy Thomas Hughes | June 21, 2026Draining the Tank: Big Oil Runs on FumesBy Jeffrey Neal Johnson | June 17, 2026Why Oracle's 10% Drop May Be Telling the Wrong StoryBy Thomas Hughes | June 12, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026Credo Technologies Accelerates AI—Its Stock Price Will FollowBy Thomas Hughes | June 18, 2026BICX, CCEL, MRAI, and CCM Company DescriptionsBiocorrx OTCMKTS:BICX$0.40 +0.06 (+17.65%) As of 09:46 AM EasternBioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.Cryo-Cell International NYSEAMERICAN:CCEL$3.61 +0.27 (+8.08%) Closing price 04:10 PM EasternExtended Trading$3.60 -0.01 (-0.28%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.Concord Medical Services NYSE:CCM$4.74 +0.35 (+7.93%) Closing price 03:59 PM EasternExtended Trading$4.74 0.00 (-0.06%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.Marpai NASDAQ:MRAI$0.70 -0.02 (-2.78%) As of 10:46 AM EasternMarpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore KBR Insiders Are Buying While the Market Misreads Its Spinoff Doug Casey Calls AI a Super Bubble, Bets on Energy, Gold Miners and Grains Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors This Edge AI Stock Just Got a Huge Vote of Confidence From Wall Street AI Is Selling Off, But These 5 Stocks Could Benefit Next MarketBeat Week in Review – 06/29 - 07/03 Analysts Just Raised Price Targets On These 3 Semiconductor Equipment Stocks Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
